Medscape uudised

Telli voog Uudisvoog Medscape uudised Medscape uudised
Latest medical news, articles, and features from Medscape Ob/Gyn & Women's Health
Uuendatud: 2 tundi 40 minutit tagasi

Unnecessary Pelvic Exams, Pap Tests Common in Young Women

6 jaanuar, 2020 - 20:36
Most bimanual pelvic exams and Pap tests in adolescents and young women were not medically indicated, putting patients at risk for harm without demonstrated commensurate benefit, a study found.
Medscape Medical News

A 'Healthy' Baby With Developmental Delay: Could It Be Zika?

6 jaanuar, 2020 - 20:36
Infants with congenital Zika virus exposure may appear healthy at birth. How would you monitor such patients? Test your knowledge with these three cases.
CDC Expert Commentary

Endometriosis: Diagnostic and Treatment Challenges

1 jaanuar, 2020 - 00:37
Noninvasive diagnostic methods and novel treatments are on the horizon for this debilitating and painful condition.
Medscape Ob/Gyn

Three Medical Centers Cancel CBP, ICE Contracts

26 detsember, 2019 - 14:07
The three universities cancelled their contracts with US Customs and Border Protection or US Immigration and Customs Enforcement after public pressure.
Medscape Medical News

The Lived Experience of Persistent Pain After Breast Cancer

24 detsember, 2019 - 22:27
A synthesis of qualitative studies explores the lived experience of persistent pain after breast cancer.
Medscape Medical News

Gender Pay Gap, Discrimination Continue in Medicine

24 detsember, 2019 - 16:24
Female physicians continue to face pay inequality and harassment by coworkers and patients, leading some to consider early retirement, a new Merritt Hawkins survey finds.
Medscape Medical News

Premature Menopause: A Warning Signal for CVD Risk

23 detsember, 2019 - 19:03
We're learning more about the effects of early menopause on a woman's health.
Medscape Ob/Gyn

'Women Don't Do Well Here': Physician Job Ad Prompts Anger

21 detsember, 2019 - 03:23
A job advertisement for a hospitalist position in Bullhead City, Arizona, sparked outrage on Twitter and has been taken down.
Medscape Medical News

FDA OKs New Antibody Drug Conjugate for HER2+ Breast Cancer

21 detsember, 2019 - 00:23
Trastuzumab deruxtecan is for the treatment of unresectable or metastatic HER2-positive breast cancer that has received two or more prior anti-HER2-based regimens in the metastatic setting.
FDA Approvals

Why Physicians Should Care About Wearables

20 detsember, 2019 - 18:20
Patient-generated data is gaining more ground. As more and more patients use them, physicians should get onboard now.
Medscape Medical News

FDA OKs First Tazarotene Lotion (Arazlo) for Acne Vulgaris

20 detsember, 2019 - 03:15
Arazlo is the first tazarotene acne treatment available in lotion form, and has been shown to provide strong efficacy with favorable tolerability, the company said.
FDA Approvals

How to Have a Better Hangover?

18 detsember, 2019 - 23:47
Does order of drinking beer and wine affect hangover severity? Or does it just not matter?
Medscape Internal Medicine

Are You Seeing Fewer Patients in Your Practice?

18 detsember, 2019 - 20:46
Two new studies suggest that the number of primary care visits in the United States is decreasing.
Medscape Reader Polls

Anastrozole Extends Breast Cancer Protection Once Stopped

18 detsember, 2019 - 17:44
A 5-year regimen of anastrozole protects women against new breast cancers for at least another 5 years they stop taking the drug.
Medscape Medical News

Omit Surgery in Early-Stage Breast Cancer? Not Yet

17 detsember, 2019 - 20:26
It's an enticing idea in an age of breast cancer treatment de-escalation: omit surgery if a patient achieves what looks like a complete response to neoadjuvant chemotherapy.
Medscape Medical News

EMA Panel Backs Adalimumab Biosimilar Amsparity

16 detsember, 2019 - 23:20
The CHMP has recommended approval of Pfizer's adalimumab biosimilar (Amsparity) for treatment of certain inflammatory and autoimmune disorders in adults and children.
International Approvals

Outcomes in TN Breast Cancer Predicted by Blood Biomarkers

16 detsember, 2019 - 20:20
Biomarkers of residual disease at surgery identify which triple-negative breast cancer patients already treated with neoadjuvant therapy will do well and which will do poorly over the next 2 years.
Medscape Medical News

Paclitaxel Pill Tops IV Response, but Needs 9-Hour Fast

14 detsember, 2019 - 01:34
Among women with metastatic breast cancer, use of an investigational oral form of paclitaxel yielded a higher overall response rate than the IV form, but administration was unique and time-consuming.
Medscape Medical News

'Remarkable' New Data on Menopausal Hormone Therapy

13 detsember, 2019 - 22:33
Estrogen alone and estrogen/progestin have opposite effects on breast cancer risk; adding progestin may lead to a lifetime of increased risk.
Medscape Medical News

ImmunoRx in TNBC: Conflicting Results

13 detsember, 2019 - 16:31
Two separate studies reach very different endpoints with addition of immunotherapy in triple-negative breast cancer. Researchers are now asking why.
Medscape Medical News